In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boots year-end results

This article was originally published in The Rose Sheet

Executive Summary

Clearasil year-end sales increased 14.4% to $144.2 mil. (£1=$1.66), UK firm reports in preliminary year-end results issued June 5. Boots Healthcare International sales jumped 12.3% to $764.1 mil. at comparable exchange rates in fiscal year ended March 31. Profit before interest for the division was up 24.1% to $116.3 mil., Boots states. Company has exited non-core businesses and is focusing on BHI and Boots the Chemists...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts